Crypto News

3 hours ago

AIM ImmunoTech (AIM) Stock Soars Nearly 100% on Japanese Cancer Treatment Patent Approval

Stocks

AIM ImmunoTech (AIM) stock jumped 97% after Japan's Patent Office approved its Ampligen cancer treatment patent covering multiple cancer types through 2039.

The post AIM ImmunoTech (AIM) Stock Soars Nearly 100% on Japanese Cancer Treatment Patent Approval appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$DBKSF$ENA$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token$SPTZ$SPX

Latest News